Top compounds associated with response to RP11-318A15.7

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.1	0.006
mRNA	Doxorubicin	CTRPv2	pan-cancer	AAC	-0.083	0.006
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.099	0.007
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.088	0.007
mRNA	Dasatinib	CTRPv2	pan-cancer	AAC	-0.097	0.008
mRNA	WZ8040	CTRPv2	pan-cancer	AAC	-0.1	0.009
mRNA	Gemcitabine	CTRPv2	pan-cancer	AAC	-0.086	0.01
mRNA	alisertib:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.091	0.01
mRNA	Cytarabine	CTRPv2	pan-cancer	AAC	-0.073	0.01
mRNA	carboplatin:etoposide (40:17 mol/mol)	CTRPv2	pan-cancer	AAC	-0.076	0.01

Download CSV